Madrigal Pharmaceuticals, Inc.【MDGL】 純利益の推移

機能の使い方
(単位:千ドル) 純利益 前年比(%)
4Q25 -58,575 -1.4%
3Q25 -114,190 +6.8%
2Q25 -42,281 -72.2%
1Q25 -73,238 -50.3%
4Q24 -59,392 -47.1%
3Q24 -106,964 +8.3%
2Q24 -151,971 +77.1%
1Q24 -147,500 +91.8%
4Q23 -112,194 +30.6%
3Q23 -98,740 +21.6%
2Q23 -85,800 +21.3%
1Q23 -76,896 +33.7%
4Q22 -85,905 +33.1%
3Q22 -81,197 +28.7%
2Q22 -70,730 +14.7%
1Q22 -57,500 +9.5%
4Q21 -64,549 +9.2%
3Q21 -63,100 +8.9%
2Q21 -61,651 +25.8%
1Q21 -52,500 +45.4%
4Q20 -59,123 +113.1%
3Q20 -57,963 +170.5%
2Q20 -49,023 +148.9%
1Q20 -36,100 +139.4%
4Q19 -27,740 +141.7%
3Q19 -21,429 +151.8%
2Q19 -19,699 +204.9%
1Q19 -15,080 +137.0%
4Q18 -11,475 +35.9%
3Q18 -8,512 +1.8%
2Q18 -6,460 -
1Q18 -6,364 -
4Q17 -8,445 -
3Q17 -8,363 -
2Q11 -12,502 -